前臨床イメージング市場：製品タイプ、イメージングモダリティ、用途、エンドユーザー別-2025-2030年の世界予測

前臨床イメージング市場は、2024年には36億9,000万米ドルとなり、2025年には38億7,000万米ドル、CAGR 4.94%で成長し、2030年には49億3,000万米ドルに達すると予測されています。

前臨床イメージングは、科学的発見と技術革新の交差点に位置し、生物医学研究の進歩に不可欠な役割を果たしています。この分野の進化は、新しい診断手法や治療戦略の開発を加速させ、動物モデル研究の精度を高め、実験結果を臨床応用に結びつける。この包括的な解説書では、現在の市場力学を探求し、研究パラダイムと技術的能力を再構築している基本的動向に焦点を当てています。急速な技術の進歩と学際的なコラボレーションにより、前臨床イメージングは医薬品開発を加速し、疾患経路を理解し、最終的にヘルスケアの転帰を改善するための礎石となっています。研究機関、製薬会社、バイオテクノロジー企業が次世代イメージングシステムに投資するにつれ、技術革新、市場セグメンテーション、地域成長機会の間に強固な相互作用が現れます。この詳細な論考は、業界動向に関する深い視点を提供し、戦略的な市場の動きに関する明確な洞察を提供すると同時に、主な発展が明確かつ正確に伝達されることを保証します。思慮深い分析と業界特有の洞察を通じて、本サマリーは前臨床イメージング技術の変革の可能性を活用することを目指す利害関係者のためのステージを設定します。

前臨床イメージング市場の変革

前臨床イメージングを取り巻く環境は、研究手法の範囲と規模を再定義した技術的躍進と進化する市場の需要に支えられ、変革的な変化を遂げています。イメージング手法の革新により、生物学的プロセスがより正確に定量化されるようになり、研究者は分子や細胞のメカニズムに関する詳細な洞察を得ることができるようになりました。この変革の時代は、高度な光学、磁気共鳴、コンピュータ断層撮影技術の統合によって特徴付けられ、画質と解像度の新たな基準を打ち立てた。ハードウェアの革新と洗練されたソフトウェアソリューションの融合は、イメージングシステムの全体的な効率を向上させただけでなく、より包括的なデータ解析を可能にしました。研究要件がますます複雑化するにつれて、学術研究、受託研究機関、および企業の医薬品開発の間で、よりダイナミックな相互作用が出現しています。技術プロバイダーが、統合されたマルチモーダルシステムを含むポートフォリオに再調整し、科学的イメージングが達成できる限界に課題していることから、戦略的再編成が明らかになっています。このような進化は、より競争の激しいマーケットプレースに拍車をかけており、今日の急速に進化するイメージングエコシステムをナビゲートするために不可欠な、俊敏な戦略と先見性のある投資の必要性を浮き彫りにしています。

市場の差別化を促進する主なセグメンテーションインサイト

セグメンテーションの洞察を掘り下げると、前臨床イメージングにおける多様なニーズに対応する市場促進要因が複雑に絡み合っていることがわかる。製品ベースのセグメンテーションに注目すると、市場調査は試薬とソフトウェア＆サービスに分類しています。試薬カテゴリー自体は、生物発光イメージング試薬、蛍光イメージング試薬、MRI造影試薬、PET放射性トレーサー、超音波造影試薬、X線CT造影試薬など、いくつかの専門領域に分かれています。各サブグループは、正確なイメージング要件に適合するよう調整されており、全体的なアッセイ感度と診断精度に貢献しています。さらに、タイプに基づくセグメンテーションでは、マルチモーダルシステムとスタンドアロンイメージングシステムが区別され、システム統合と運用の拡張性におけるさまざまな嗜好が反映されます。画像モダリティのセグメンテーションに移行すると、市場には磁性粒子画像、磁気共鳴画像、マイクロコンピューテッド・トモグラフィ、光学画像、陽電子放射断層撮影、単一光子放射断層撮影などの技術が含まれます。アプリケーションベースのセグメンテーションでは、心臓病学、医薬品開発、免疫学および炎症、感染症、神経学、腫瘍学などの領域を探ることで、市場をさらに細分化しています。エンドユーザーセグメンテーションでは、学術・研究機関、受託研究機関、製薬・バイオテクノロジー企業の関与が強調されています。これらの多層的なセグメンテーションの洞察は、革新的であると同時に多様な市場を示しており、ターゲットを絞った戦略的イニシアチブと、進化する研究と診断のニーズに対応するテーラーメイドのソリューションセットの舞台を設定しています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の増加により、より優れた画像診断ソリューションの需要が高まっています。
    • 精密医療と個別化治療手法への注目の高まり
    • 世界中で医薬品研究開発活動への投資が増加
  • 抑制要因
    • 浸透深度の制限と解像度の問題
  • 機会
    • 前臨床イメージング技術の進歩
    • 可視化と分析能力を強化する3Dイメージングモダリティの開発
  • 課題
    • 動物調査に関連する厳しい規制と倫理的懸念
• 市場セグメンテーション分析
  • 製品：定量分析能力により、MRI造影剤およびPET放射性トレーサーの需要が高まっています。
  • 応用：心臓病学における前臨床イメージングの応用拡大による病態生理の理解と治療介入の評価
  • エンドユーザー：製薬会社およびバイオ製薬会社による新薬開発における前臨床イメージングの採用増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 前臨床イメージング市場：製品別

• 試薬
  • 生物発光イメージング試薬
  • 蛍光イメージング試薬
  • MRI造影剤
  • PET放射性トレーサー
  • 超音波造影剤
  • X線CT造影剤
• ソフトウェアとサービス

第7章 前臨床イメージング市場：タイプ別

• マルチモーダルシステム
• スタンドアロン画像システム

第8章 前臨床イメージング市場画像診断法別

• 磁性粒子イメージング
• 磁気共鳴画像法
• マイクロコンピュータ断層撮影
• 光学イメージング
• 陽電子放出断層撮影
• 単一光子放出コンピュータ断層撮影

第9章 前臨床イメージング市場：用途別

• 心臓病学
• 医薬品開発
• 免疫学と炎症
• 感染症
• 神経学
• 腫瘍学

第10章 前臨床イメージング市場：エンドユーザー別

• 学術調査機関
• 契約調査機関
• 製薬・バイオテクノロジー企業

第11章 南北アメリカの前臨床イメージング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の前臨床イメージング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの前臨床イメージング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Advanced Molecular Vision, Inc.
• Agilent Technologies, Inc.
• Angstrom Advanced Inc.
• Aspect Imaging Ltd.
• AXT Pty Ltd
• Berthold Technologies
• Bruker Corporation
• Cubresa, Inc.
• Euro-BioImaging ERIC
• FUJIFILM Holdings America Corporation
• GE HealthCare Technologies Inc.
• IVIM Technology Corp.
• KUB Technologies, Inc.
• LI-COR, Inc.
• Mediso Ltd.
• Milabs B.V.
• Miltenyi Biotec GmbH
• MR Solutions Ltd.
• Peira bvba
• PerkinElmer Inc.
• Revvity, Inc.
• Scitech Pty Ltd
• Siemens AG
• TriFoil Imaging
• United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

• FIGURE 1. PRECLINICAL IMAGING MARKET MULTI-CURRENCY
• FIGURE 2. PRECLINICAL IMAGING MARKET MULTI-LANGUAGE
• FIGURE 3. PRECLINICAL IMAGING MARKET RESEARCH PROCESS
• FIGURE 4. PRECLINICAL IMAGING MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. PRECLINICAL IMAGING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PRECLINICAL IMAGING MARKET DYNAMICS
• TABLE 7. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MULTIMODAL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY STANDALONE IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 57. CANADA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. CANADA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 59. CANADA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CANADA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 61. CANADA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 62. CANADA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 89. CHINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. CHINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 91. CHINA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. CHINA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 93. CHINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 94. CHINA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 95. INDIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. INDIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 97. INDIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. INDIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 99. INDIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 100. INDIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 103. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 105. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 106. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 109. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 111. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 112. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 115. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 117. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 118. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 121. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 123. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 124. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 127. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 129. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 130. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 135. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 136. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 139. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 141. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 142. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 145. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 147. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 148. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 151. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 153. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 154. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 161. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 164. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 166. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 167. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 170. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 172. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 173. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 176. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 178. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 179. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 182. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 184. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 185. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 188. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 190. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 191. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 194. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 195. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 196. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 197. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 198. ITALY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. ITALY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 200. ITALY PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 201. ITALY PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 202. ITALY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 203. ITALY PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 206. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 207. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 208. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 209. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 212. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 213. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 214. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 215. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 218. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 219. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 220. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 221. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 222. POLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. POLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 224. POLAND PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 225. POLAND PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 226. POLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 227. POLAND PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 228. QATAR PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. QATAR PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 230. QATAR PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 231. QATAR PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 232. QATAR PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 233. QATAR PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 236. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 237. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 238. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 239. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 242. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 244. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 245. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 250. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 251. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 254. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 255. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 256. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 257. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 260. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 261. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 262. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 263. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 266. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 267. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 268. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 269. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 272. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 273. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 274. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 275. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 280. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 281. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
• TABLE 284. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
• TABLE 286. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 287. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 288. PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 289. PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

The Preclinical Imaging Market was valued at USD 3.69 billion in 2024 and is projected to grow to USD 3.87 billion in 2025, with a CAGR of 4.94%, reaching USD 4.93 billion by 2030.

Preclinical imaging stands at the intersection of scientific discovery and technological innovation, playing an indispensable role in advancing biomedical research. The evolution of this field has accelerated the development of novel diagnostic methodologies and therapeutic strategies, thereby enhancing the precision of animal model studies and the translation of experimental results into clinical applications. This comprehensive narrative explores the current market dynamics, highlighting the foundational trends that are reshaping research paradigms and technological capabilities. Marked by rapid technological advancements and interdisciplinary collaboration, preclinical imaging has become a cornerstone for accelerating drug development, understanding disease pathways, and ultimately improving healthcare outcomes. As research institutions, pharmaceutical companies, and biotechnology entities invest in next-generation imaging systems, a robust interplay emerges between innovation, market segmentation, and regional growth opportunities. This detailed discussion offers an in-depth perspective on industry trends, providing clear insights into strategic market moves while ensuring that key developments are communicated with clarity and precision. Through thoughtful analysis and industry-specific insights, this summary sets the stage for stakeholders aiming to harness the transformative potential of preclinical imaging technologies.

Transformative Shifts in the Preclinical Imaging Landscape

The preclinical imaging landscape has undergone transformative shifts, underpinned by technological breakthroughs and evolving market demands that have redefined the scope and scale of research methodologies. Innovations in imaging modalities now facilitate more precise quantification of biological processes, enabling researchers to capture detailed insights about molecular and cellular mechanisms. This era of transformation is marked by the integration of advanced optics, magnetic resonance, and computed tomography technologies which have set new benchmarks in image quality and resolution. The convergence of hardware innovation with sophisticated software solutions has not only improved the overall efficiency of imaging systems but has also allowed for more comprehensive data analysis. As research requirements have become increasingly complex, a more dynamic interplay between academic research, contract research organizations, and corporate drug development has emerged. Strategic realignments are evident as technology providers recalibrate their portfolios to include integrated multimodal systems, pushing the boundaries of what scientific imaging can achieve. This evolution is driving a more competitive marketplace, spotlighting the need for agile strategies and forward-thinking investments that are essential to navigate today's rapidly evolving imaging ecosystem.

Key Segmentation Insights Driving Market Differentiation

Delving into the segmentation insights reveals a complex matrix of market drivers that cater to diverse needs in preclinical imaging. When focusing on product-based segmentation, market studies dissect the offerings into reagents and software & services. The reagent category itself unfolds into several specialized domains including bioluminescent imaging reagents, fluorescent imaging reagents, MRI contrasting reagents, PET radioactive tracers, ultrasound contrasting reagents, and X-ray CT contrasting reagents. Each subgroup is tailored to meet precise imaging requirements, contributing to overall assay sensitivity and diagnostic accuracy. Additionally, a segmentation based on type distinguishes between multimodal systems and standalone imaging systems, reflecting varied preferences in system integration and operational scalability. Transitioning to imaging modality segmentation, the market encompasses technologies such as magnetic particle imaging, magnetic resonance imaging, micro-computed tomography, optical imaging, positron emission tomography, and single-photon emission computed tomography. The application-based segmentation further refines the market by exploring domains like cardiology, drug development, immunology and inflammation, infectious diseases, neurology, and oncology. End-user segmentation highlights the involvement of academic and research institutes, contract research organizations, and pharmaceutical & biotechnology companies. These multi-layered segmentation insights illustrate a market that is as diverse as it is innovative, setting the stage for targeted strategic initiatives and tailored solution sets that meet evolving research and diagnostic needs.

Based on Product, market is studied across Reagents and Software & Services. The Reagents is further studied across Bioluminescent Imaging Reagents, Fluorescent Imaging Reagents, MRI Contrasting Reagents, PET Radioactive Tracers, Ultrasound Contrasting Reagents, and X-ray CT Contrasting Reagents.

Based on Type, market is studied across Multimodal Systems and Standalone Imaging Systems.

Based on Imaging Modality, market is studied across Magnetic Particle Imaging, Magnetic Resonance Imaging, Micro-Computed Tomography, Optical Imaging, Positron Emission Tomography, and Single-Photon Emission Computed Tomography.

Based on Applications, market is studied across Cardiology, Drug Development, Immunology & Inflammation, Infectious Diseases, Neurology, and Oncology.

Based on End Users, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.

Key Regional Insights and Emerging Global Opportunities

Geographical analysis of the preclinical imaging market underscores significant regional variations that are driving global opportunities. In the Americas, robust investment in biomedical research coupled with established networks of academic and healthcare institutions has created a fertile landscape for the adoption of advanced imaging technologies. This region benefits from substantial funding for both public and private sector projects, which continually fuel innovation and market expansion. The Europe, Middle East & Africa region showcases a dynamic blend of longstanding research traditions alongside aggressive modernization efforts. Advances in regulatory frameworks and collaborative research initiatives enhance the pace of technology adoption, while strategic partnerships are fostering cross-border innovation. Meanwhile, the Asia-Pacific region emerges as a rapidly growing hub due to burgeoning demand from rising economies, expanding research infrastructures, and increased governmental support for high-tech medical research. The unique mix of emerging markets and resilient industrial capabilities in these regions is catalyzing a more competitive global market, driving investment in new modalities and supporting the transition toward more versatile, agile imaging solutions. These regional insights paint a picture of a truly global marketplace, where diverse regional strengths complement each other in a symbiotic drive toward transformative preclinical imaging breakthroughs.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights Steering Technological Advancements

The preclinical imaging market is witnessing vigorous competitive dynamics as key companies continue to spearhead innovation and collaboration across the spectrum of imaging technologies. Industry leaders such as Advanced Molecular Vision, Inc., Agilent Technologies, Inc., and Angstrom Advanced Inc. are at the forefront, pushing technological boundaries with continuous investments in research and development. Firms like Aspect Imaging Ltd. and AXT Pty Ltd underscore the shift towards niche innovations while Berthold Technologies and Bruker Corporation expand their product portfolios to cover emerging imaging modalities. Other notable players, including Cubresa, Inc., Euro-BioImaging ERIC, and FUJIFILM Holdings America Corporation, are instrumental in integrating state-of-the-art technologies with scalable imaging systems. GE HealthCare Technologies Inc., IVIM Technology Corp., KUB Technologies, Inc., and LI-COR, Inc. are setting high standards in precision and reliability, while Mediso Ltd. and Milabs B.V. deliver advanced solutions that cater to both academic and industrial research demands. Companies such as Miltenyi Biotec GmbH, MR Solutions Ltd., Peira bvba, PerkinElmer Inc., Revvity, Inc., Scitech Pty Ltd., Siemens AG, TriFoil Imaging, and United Imaging Healthcare Co., Ltd. further consolidate this ecosystem with their robust portfolios and strategic market collaborations. Collectively, these industry stalwarts not only drive technological progress but also foster an environment of competitive excellence and sustained innovation.

The report delves into recent significant developments in the Preclinical Imaging Market, highlighting leading vendors and their innovative profiles. These include Advanced Molecular Vision, Inc., Agilent Technologies, Inc., Angstrom Advanced Inc., Aspect Imaging Ltd., AXT Pty Ltd, Berthold Technologies, Bruker Corporation, Cubresa, Inc., Euro-BioImaging ERIC, FUJIFILM Holdings America Corporation, GE HealthCare Technologies Inc., IVIM Technology Corp., KUB Technologies, Inc., LI-COR, Inc., Mediso Ltd., Milabs B.V., Miltenyi Biotec GmbH, MR Solutions Ltd., Peira bvba, PerkinElmer Inc., Revvity, Inc., Scitech Pty Ltd, Siemens AG, TriFoil Imaging, and United Imaging Healthcare Co., Ltd.. Actionable Recommendations for Industry Leaders to Accelerate Growth

Industry leaders are encouraged to adopt multifaceted strategies to capitalize on the evolving opportunities within the preclinical imaging market. First and foremost, it is essential to channel investments toward research and development initiatives that stimulate innovative imaging technologies and system integrations. Leaders should prioritize partnerships with both established institutions and emerging technology providers to leverage comprehensive product portfolios and cross-disciplinary expertise. Fostering collaboration between academia, contract research organizations, and industry stakeholders can further enhance the development of specialized imaging reagents and modalities. Embracing digital transformation and incorporating advanced analytics into imaging workflows will not only improve operational efficiency but also facilitate more accurate diagnostics and research outcomes. In parallel, a regional focus can amplify market impact: tailoring strategies based on regional insights from the Americas, Europe, Middle East & Africa, and Asia-Pacific will ensure that products align with local regulatory environments and research priorities. These actionable recommendations, combined with an emphasis on agility and customer-centric innovation, can empower leaders to drive growth, boost competitive advantage, and realize sustained market leadership in an increasingly dynamic technological landscape.

Conclusion: Charting a Forward-Thinking Path for Preclinical Imaging

In conclusion, the preclinical imaging landscape is characterized by a blend of technological innovation, diverse market segmentation, and robust regional dynamics that collectively shape its future trajectory. This comprehensive analysis underscores the importance of understanding market complexity-from product differentiation and imaging modalities to nuanced end-user and application insights. The evolving narrative within this sector is also influenced by transformative regional opportunities and the concerted efforts of key industry players who continue to push the boundaries of scientific imaging. As advancements in hardware and software converge to deliver more precise, reliable, and versatile imaging solutions, stakeholders are better positioned to address the challenges of modern biomedical research. This convergence of innovation, strategic collaboration, and targeted investment not only drives competitive excellence but also paves the way for breakthroughs that promise to revolutionize diagnostics and therapeutic interventions. As the industry moves forward, a clear focus on agility, research collaboration, and technology integration will be paramount in sustaining momentum and achieving long-term success.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic diseases fostering demand for better imaging solutions
    • 5.1.1.2. Rising focus on precision medicine and personalized treatment methodologies
    • 5.1.1.3. Increasing investments in pharmaceutical research and development activities worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. Limited depth of penetration & resolution issues
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in the preclinical imaging technologies
    • 5.1.3.2. Development of 3D imaging modalities enhancing visualization and analysis capabilities
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulations and ethical concerns associated with animal research
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing preference for MRI contrasting reagents and PET radioactive tracers owing to their quantitative analysis capability
  • 5.2.2. Application: Expanding application of preclinical imaging in cardiology for understanding pathophysiology and evaluating therapeutic interventions
  • 5.2.3. End-User: Increasing adoption of preclinical imaging by pharmaceutical & biopharmaceutical companies to develop new drugs
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Preclinical Imaging Market, by Product

• 6.1. Introduction
• 6.2. Reagents
  • 6.2.1. Bioluminescent Imaging Reagents
  • 6.2.2. Fluorescent Imaging Reagents
  • 6.2.3. MRI Contrasting Reagents
  • 6.2.4. PET Radioactive Tracers
  • 6.2.5. Ultrasound Contrasting Reagents
  • 6.2.6. X-ray CT Contrasting Reagents
• 6.3. Software & Services

7. Preclinical Imaging Market, by Type

• 7.1. Introduction
• 7.2. Multimodal Systems
• 7.3. Standalone Imaging Systems

8. Preclinical Imaging Market, by Imaging Modality

• 8.1. Introduction
• 8.2. Magnetic Particle Imaging
• 8.3. Magnetic Resonance Imaging
• 8.4. Micro-Computed Tomography
• 8.5. Optical Imaging
• 8.6. Positron Emission Tomography
• 8.7. Single-Photon Emission Computed Tomography

9. Preclinical Imaging Market, by Applications

• 9.1. Introduction
• 9.2. Cardiology
• 9.3. Drug Development
• 9.4. Immunology & Inflammation
• 9.5. Infectious Diseases
• 9.6. Neurology
• 9.7. Oncology

10. Preclinical Imaging Market, by End Users

• 10.1. Introduction
• 10.2. Academic & Research Institutes
• 10.3. Contract Research Organizations
• 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Preclinical Imaging Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Preclinical Imaging Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Preclinical Imaging Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. NurExone's ExoPTEN preclinical data highlights potential for transforming optic nerve damage treatment
  • 14.3.2. Bruker's strategic acquisition of Spectral Instruments Imaging strengthens its position in preclinical in-vivo optical imaging systems
  • 14.3.3. Preclinical imaging research aims to help refine deep brain stimulation for stroke recovery
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced Molecular Vision, Inc.
• 2. Agilent Technologies, Inc.
• 3. Angstrom Advanced Inc.
• 4. Aspect Imaging Ltd.
• 5. AXT Pty Ltd
• 6. Berthold Technologies
• 7. Bruker Corporation
• 8. Cubresa, Inc.
• 9. Euro-BioImaging ERIC
• 10. FUJIFILM Holdings America Corporation
• 11. GE HealthCare Technologies Inc.
• 12. IVIM Technology Corp.
• 13. KUB Technologies, Inc.
• 14. LI-COR, Inc.
• 15. Mediso Ltd.
• 16. Milabs B.V.
• 17. Miltenyi Biotec GmbH
• 18. MR Solutions Ltd.
• 19. Peira bvba
• 20. PerkinElmer Inc.
• 21. Revvity, Inc.
• 22. Scitech Pty Ltd
• 23. Siemens AG
• 24. TriFoil Imaging
• 25. United Imaging Healthcare Co., Ltd.